Ricolinostat

Generic Name: Ricolinostat

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₄H_₂₇N_₅O_₃

CAS Number: 1316214-52-4

Unique Ingredient Identifier: WKT909C62B

Background: Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Diabetic Peripheral Neuropathy Treatment Market 2034

Diabetic Peripheral Neuropathy market to surge due to increasing prevalence and awareness, with multiple-stage pipeline products revolutionizing market dynamics. Key companies include Grünenthal, Averitas Pharma, Daiichi Sankyo, Vertex Pharmaceuticals, Helixmith, and Lexicon Pharmaceuticals. Emerging therapies such as QUTENZA (capsaicin) and TARLIGE (mirogabalin besylate) are expected to drive market growth.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy